C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
Vave Health has launched Universal Wireless Probe, a hand-held device aimed at improving diagnostics in various clinical ...
Helius’ new subsidiary, Revelation Neuro, will target a non-implantable form of BCI. Helius Medical Technologies is muscling ...
University of Turku researchers have developed sensors from single-wall carbon nanotubes for continuous health monitoring.
The FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.
Eye cancer is rare, accounting for less than 1% of all new cancer cases in the UK. Image credit: Leonardo Gabriel Tallone via ...